NDAORALSOLUTION
Approved
Dec 2014
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
POKONZA (potassium chloride) by Ascentage Pharma is (k+) is the principal intracellular cation of most body tissues. First approved in 2014.
Drug data last refreshed 11h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
POKONZA is an oral potassium chloride solution approved in 2014 for treating potassium deficiency (hypokalemia) in patients with depleted body stores. Potassium is the principal intracellular cation essential for nerve impulse transmission, muscle contraction, and maintaining normal cardiac and renal function. The drug replaces depleted intracellular and extracellular potassium to restore normal electrolyte balance.
Peak12.5 years to LOE
Product is at peak maturity with stable, established market presence; brand team is likely optimized for efficiency rather than growth expansion.
Mechanism of Action
(K+) is the principal intracellular cation of most body tissues. Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity; the transmission of nerve impulses; the contraction of cardiac, skeletal, and smooth muscle; and the…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on POKONZA offers stable, mature-stage pharmaceutical experience focused on market access, pricing strategies, and defending market share against generic competition in a commoditized electrolyte category. This role emphasizes commercial execution, cost management, and payer relations rather than clinical innovation, making it suitable for professionals seeking predictable career progression in established products.
Worked on POKONZA at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.